|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Atea Pharmaceuticals (NASDAQ: AVIR) through any online brokerage.
The latest price target for Atea Pharmaceuticals (NASDAQ: AVIR) was reported by Morgan Stanley on 2021-04-06. The analyst firm set a price target for 82.00 expecting AVIR to rise to within 12 months (a possible 45.11% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $56.51 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Atea Pharmaceuticals.
There is no upcoming split for Atea Pharmaceuticals.